Ajanta Pharma Limited
AJANTPHARM
Rang în acțiuni
#3730
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Preț acțiune
$35.98
Capitalizare de piață
$4.50B
Schimbare (1 zi)
-1.18%
Schimbare (1 an)
29.38%
Țară
IN
Tranzacționează Ajanta Pharma Limited (AJANTPHARM)
Categorie
Healthcare
Venituri pentru Ajanta Pharma Limited (AJANTPHARM)
Venituri în Jun 2026 TTM: $637.45M
Conform celor mai recente rapoarte financiare ale Ajanta Pharma Limited, venitul actual al companiei (TTM) este $637.45M. În anul 2024, compania a avut un venit de $504.74M o creștere față de venitul din anul 2023, care a fost de $455.42M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Ajanta Pharma Limited din 2005 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2026 (TTM) | $637.45M | 17.29% |
| 2025 | $543.47M | 7.67% |
| 2024 | $504.74M | 10.83% |
| 2023 | $455.42M | 5.26% |
| 2022 | $432.64M | 11.24% |
| 2021 | $388.92M | 14.37% |
| 2020 | $340.05M | 17.10% |
| 2019 | $290.39M | -8.20% |
| 2018 | $316.32M | 7.04% |
| 2017 | $295.52M | 14.66% |
| 2016 | $257.74M | 10.53% |
| 2015 | $233.19M | 18.34% |
| 2014 | $197.05M | 16.14% |
| 2013 | $169.67M | 27.01% |
| 2012 | $133.59M | 17.92% |
| 2011 | $113.29M | 24.79% |
| 2010 | $90.78M | 31.92% |
| 2009 | $68.81M | -10.99% |
| 2008 | $77.31M | 29.89% |
| 2007 | $59.52M | 15.41% |
| 2006 | $51.57M | 13.41% |
| 2005 | $45.48M | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 937.20% |
IN
|
